# EndoVas

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/endovas

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Total disclosed funding: $16M
- Latest round: Series A (Dec 30, 2021)
- Investors on record: 5

## About

Established in 2018 and based in Shanghai, China, EndoVas operates as a medical device developer that mainly provides solutions for peripheral venous disease. The founder of the company, Shengqiang Wang graduated from the East China University of Science and Technology. In April 2024, the company launched the V-Mixtent® venous stent. In February 2025, it closed venture funding from new investor Anhui Xinhua Group Investment.

The company focuses on the research and development and production of vascular interventional medical products. The products that have been launched include the V-Mixtent® venous stent system and the syringe-assisted propulsion pump. The V-Mixtent® venous stent is suitable for three diseases, which are non-thrombotic iliac vein compression syndrome (NIVCS), deep vein thrombosis (DVT), and post-deep vein thrombosis syndrome (PTS). Products under development or in the patent stage include the venous closure system, V-CLOFF® deep vein thrombosis removal system, and vascular filtration protection device.

The company generates revenue by providing vascular interventional medical products such as V-Mixtent® venous stent system and the syringe-assisted propulsion pump.

The company will use the venture funding to accelerate the promotion and construction of the company's domestic marketing network, promote new product registration, expand the international market, and accelerate the commercialization of the company's R&D results.

## Funding rounds

- Series A, Dec 30, 2021, $16M — MED-FINE Capital, Furong Capital, Lake Ventures, Huayu Investment Management, Shanghai Zhiyi Chengxi Asset Management

## Investors

- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Series A
- Furong Capital (https://capitalatlas.ai/funds/furong-capital) — Series A
- Lake Ventures — Series A
- Huayu Investment Management (https://capitalatlas.ai/funds/huayu-investment-management) — Series A
- Shanghai Zhiyi Chengxi Asset Management — Series A